Management of Catatonia

Antipsychotic Selection and Monitoring

• The American Academy of Child and Adolescent Psychiatry recommends starting with an atypical antipsychotic, such as risperidone 0.25-0.5mg at bedtime or olanzapine 2.5-5mg at bedtime, due to their lower risk of extrapyramidal symptoms that could worsen or trigger catatonia 1, 3
• Atypical antipsychotics have a significantly lower risk of extrapyramidal symptoms and tardive dyskinesia compared to typical antipsychotics, which is critical in patients who have just recovered from catatonia 1, 2
• Typical antipsychotics carry a 50% risk of tardive dyskinesia after 2 years of continuous use in vulnerable populations 1, 2
• Benzodiazepines, such as lorazepam, can be used as adjuncts to antipsychotics to help stabilize the clinical situation during the acute phase of treatment 4, 3
• The American Academy of Child and Adolescent Psychiatry suggests that antipsychotic therapy should be implemented for a minimum of 4-6 weeks at adequate dosages before determining efficacy 4, 3
• If no response is seen after 4-6 weeks or unmanageable side effects occur, switching to a different antipsychotic is recommended 4, 3
• Most patients with schizophrenia require long-term antipsychotic therapy to prevent relapse, with approximately 65% of patients relapsing within 1 year without maintenance treatment, compared to 30% on antipsychotics 3
• The American Academy of Child and Adolescent Psychiatry recommends reassessing dosage periodically to ensure the lowest effective dose and maintaining physician contact at least monthly to monitor symptoms, side effects, and compliance 3
• Clozapine is the only antipsychotic with documented superiority for treatment-resistant cases and should be considered if there is an inadequate response to 2 adequate trials of different antipsychotics 3